stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / BIIB / Net Income

Biogen Inc. Net Income 2007–2025

Biogen Inc. (BIIB) annual net income by fiscal year, computed from SEC filings. Compound growth +4.0%/yr over 18 years.

Fiscal yearNet IncomeNet marginChange (YoY)
FY 2025$1.29B13.1%-20.8%
FY 2024$1.63B16.9%+40.6%
FY 2023$1.16B11.8%-61.9%
FY 2022$3.05B29.9%+95.8%
FY 2021$1.56B14.2%-61.1%
FY 2020$4.00B29.8%-32.1%
FY 2019$5.89B41.0%+32.9%
FY 2018$4.43B32.9%+74.5%
FY 2017$2.54B20.7%-31.4%
FY 2016$3.70B32.3%+4.4%
FY 2015$3.55B33.0%+20.9%
FY 2014$2.93B30.2%+57.6%
FY 2013$1.86B26.9%+34.9%
FY 2012$1.38B25.0%+11.8%
FY 2011$1.23B24.5%+22.8%
FY 2010$1.01B21.3%+3.6%
FY 2009$970.13M22.2%+23.9%
FY 2008$783.17M19.1%+22.7%
FY 2007$638.17M20.1%

Source: Biogen Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Biogen Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Biogen Inc. — frequently asked questions

What is Biogen Inc.'s net income?

Biogen Inc. (BIIB) reported net income of $1.29B for fiscal year 2025, per its SEC filings.

How has Biogen Inc.'s net income changed over time?

Between fiscal 2007 and 2025, BIIB's net income grew at roughly 4.0% per year (compound annual rate), from $638.17M to $1.29B.

Where does this data come from?

Figures are computed from Biogen Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More BIIB financial history

Full BIIB fundamentals page → · All 1,500+ companies →